CAS RN: 5610-49-1
1-Butylpiperazine
Product Availability
Choose a grade to view its available package options.
9 package records7 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20251006 | 100g | Out of stock | Inquiry | ||
| Batchno.20260425 | 1g | In stock | Shanghai | Inquiry | |
| Batchno.20260219 | 1ml / 5ml / 25ml / 100ml | Confirm by inquiry | Shanghai, Shandong | Inquiry | |
| Batchno.20251218 | 25g | In stock | Shanghai | Inquiry | |
| Batchno.20250420 | 5g | In stock | Shanghai | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20250210 | 5ml | Out of stock | 8-10 business days | Inquiry |
- Product code: SSC-164053
Historical Factory Record
Historical Supply Reference
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
- Pack sizes on record: 100g
- Available purity: ＞97%
- Inventory rows with stock: 0
- Bulk packaging: confirmed by inquiry
Reference Pack Sizes
Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.
| Pack Size | Recorded Purity | Available Qty | Ship From | Inquiry |
|---|---|---|---|---|
| 100g | ＞97% | 0 Out of Stock | Beijing | Inquiry |
5610-49-1 / 1-butylpiperazine
Basic Information
CAS
5610-49-1
Multi CAS
No
Molecular Formula
C8H18N2
Molecular Weight
142.240000
Exact Mass
142.146999
InChI
InChI=1S/C8H18N2/c1-2-3-6-10-7-4-9-5-8-10/h9H,2-8H2,1H3
InChIKey
YKSVXVKIYYQWBB-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
10
Fraction Csp3
1
Rotatable bonds
3
H-bond acceptors
2
H-bond donors
1
Molar refractivity
44.22
TPSA
15.27
LogP / Solubility
WLOGP
0.69
MLOGP
0.6
XLogP3
0.9
Consensus LogP
0.73
Log S (ESOL)
-0.96
Class (ESOL)
Very soluble
Log S (Ali)
-1.23
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.52
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.1
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5
